Gates Foundation awards $5 million for COVID-19 therapeutics research

The grant to Kleo Pharmaceuticals will support efforts to advance development of a COVID-19 hyperimmune globulin mimic therapeutic that could provide a synthetic, homogenous, readily available replacement for convalescent serum, which has shown promise as a treatment for COVID-19….

Philanthropy News Digest |

Goto full post >>